Chiral capillary electrophoretic determination of the enantiomeric purity of homocamptothecin derivatives, promising antitumor topoisomerase I inhibitors, using highly sulfated CDs and flourescense detection

Electrophoresis

Volumn 27, Issue 23, 2006, Pages 4717-4729

  Goossens, Jean François ^a   Mahieu, Christine ^b   Dias, Nathalie ^b   Bailly, Christian ^b   Principe, Paola ^c   Bonte, Jean Paul ^a   Lansiaux, Amélle ^b   Vaccher, Claude ^a   Foulon, Catherine ^a  

^a UNIV LILLE   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c Institut Henri Beaufour   (France)

Author keywords

Chiral CE; Enantiomeric purity; Flourescence detection; Highly sulfated CDs; Homocamptothecin derivatives

Indexed keywords

ENANTIOMERS; FLUORESCENCE;

APPLIED FIELD; BUFFER PH; CHIRAL CE; ENANTIOMERIC PURITY; FLOURESCENCE DETECTION; HIGHLY SULPHATED CD; HOMOCAMPTOTHECIN DERIVATIVE; PHOSPHATE BUFFERS; S(Β); Β-CD;

TEMPERATURE CONTROL;

ACETONITRILE; ANTINEOPLASTIC AGENT; BETA CYCLODEXTRIN; BN 80745; BN 80765; BN 80875; BN 80914; BN 80927; BN 80928; BUFFER; CAMPTOTHECIN DERIVATIVE; DIFLOMOTECAN; DNA TOPOISOMERASE INHIBITOR; IRINOTECAN; PHOSPHATE; TOPOTECAN; TRIETHANOLAMINE;

ACIDITY; ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CHIRALITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; ENANTIOMER; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PH; RADIATION DETECTION; SULFATION; TEMPERATURE; TIME; TRANSPORT KINETICS; ULTRAVIOLET RADIATION;

EID: 33845585441     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200600143     Document Type: Article

References (42)

1. Lerchen, H. G., Idrugs 1999, 2, 896-906.
2. Bailly, C., Crit. Rev. Oncol. Hematol. 2003, 45, 91-108.
3. Sawada, S., Matsuoka, S., Nokata, K., Nagata, H. et al., Chem. Pharm. Bull. (Tokyo) 1991, 39, 3183-3188.
4. Kingsbury; W. D., Bśhm, J. C., Jakas, D. R., Holden, K. G. et al., J. Med. Chem. 1991, 34, 98-107.
5. Lavergne, O., Lesueur-Ginot, L., Pia Rodas, F., Bigg, D. C. H., Bioorg. Med. Chem. Let. 1997, 7, 2235-2238.
6. Lesueur-Ginot, L., Demarquay, D., Kiss, R., Kasprzyk, P. G., et al., Cancer Res. 1999, 59, 2939-2943.
7. Bailly, C., Lansiaux, A., Dassonneville, L., Demarquay, D. et al., Biochemistry 1999, 38, 15556-15563.
8. Lavergne, O., Lesueur-Ginot, L., Pla Rodas, F., Kasprzyk, P. G. et al., J. Med. Chem. 1998, 41, 5410-5419.
9. Lavergne, O., Demarquay, D., Bailly, C., Lanco, C. et al., J. Med. Chem. 2000, 43, 2285-2289.
10. Bonneterre, J., Cotti, P., Adenis, A., Bonneterre, M. E. et al., Proc. Am. Assoc. Cancer Res. A 2000, 234, 11-19.
11. Lansiaux, A., Facompré, M., Wattez, N., Hildebrand, M. P. et al., Mol. Pharmacol. 2001, 60, 450-461.
12. Demarquay, D., Huchet, M., Coulomb, H., Lesueur-Ginot, L. et al., Anti-Cancer Drugs 2001, 12, 9-19.
13. Lavergne, O., Harnett, J., Rolland, A., Lanco, C. et al., Bioorg. Med. Chem. Let. 1999, 9, 2599-2602.
14. Huchet, M., Demarquay, D., Coulomb, H., Kasprzyk, P. G. et al., Ann. N. Y. Acad. Sci. 2000, 922, 303-305.
15. Wari, M. C., Nicholas, A. W., Wall, M. E., J. Med. Chem. 1987, 30, 2317-2319.
16. Demarquay, D., Huchet, M., Coulomb, H., Lesueur-Ginot, L. et al., Cancer Res. 2004, 64, 4942-4949.
17. Goossens, J. F., Foulon, C., Bailly, C., Bigg, D. C. H. et al., Chromatographia 2004, 59, 305-313.
18. Chankvetadze, B., Capillary Electrophoresis in Chiral Analysis, Wiley & Sons, Chichester 1997.
19. Garcia-Ruiz, C., Marina, M. L., Electrophoresis 2006, 27, 195-212.
20. Xu, L., Feng, Y. Q., Shi, Z. G., Da, S. L. et al., J. Chromatogr. A 2004, 1033, 161-166.
21. Imura, A., Itoh, M., Miyadera, A., Tetrahedron: Asymmetry 1998, 9, 2285-2291.
22. Kagel, J. R,. Stella, V. J., Riley, C. M., J. Pharm. Biomed. Anal. 1993, 11, 793-802.
23. Kang, J., Kumar, V., Yang, D., Chowdhury, P. R. et al., Eur J. Pharm. Sci. 2002, 15, 163-170.
24. Saetern, A. M., Nguyen, B. N., Bauer-Brandl, A., Brandl M., Int. J. Pharm. 2004, 284, 61-68.
25. Cheng, J., Khin, K. T., Davis, M. E., Mol. Pharm. 2004, 1, 183-193.
26. Schluep, T., Cheng, J., Khin, K. T., Cancer Chemother. Pharmacol. 2006, 57, 654-662.
27. Chen F. T., Shen G., Evangelista R. A., J. Chromatogr. A 2001, 924, 523-532.
28. Fassberg, J., Stella, V. J., J. Pharm. Sci. 1992, 81, 676-684.
29. Dean, J. A., Lange's Handbook of Chemistry, Mc Graw-Hill Inc., New York 1992.
30. Verleysen, K., Van den Bosch, T., Sandra, P., Electrophoresis 1999, 20, 2650-2655.
31. Danel, C., Lipka, E., Bonte, J. P., Goossens, J. F. et al., Electrophoresis 2005, 26, 3824-3832.
32. Wren, S. A., Rowe, R. C., J. Chromatogr. 1992, 603, 235-241.
33. Wren, S. A., Rowe, R. C., J. Chromalogr. 1993, 635, 113-118.
34. Palmamdotir, S., Edholm, L E., J. Chromatogr. A, 1994, 666, 337-350.
35. Stafaati, A., Clark B. J., Anal. Proc, 1993, 30, 481-488.
36. Strogo, M. A., Lagu, A. L, J. Chromatogr. 1993, 16, 51-68.
37. Altria K., Fabre, H., Chromatrophia 1995,40, 313-320.
38. Isaaq, H. J., Atamma, I. Z., Muschik G. M., Janini, G. M., Chromatograpia 1991, 32, 155-161.
39. Foulon, C, Danal, C., Vaccher, M. P., Boryte, J. P. et al., Electrophoresis 2004, 25, 2735-2744.
40. Altria K. D,. Capilliary Electrophoresis Guidebook: Principles, Instrumentation, and Application Humana Press, Totowa, NJ 1996 NO, pp. 49-60.
41. Proosedings of the International Conference on Harmonization (ICH) of Technical Requirements for Registration of Phamaceuticals for Human Use, IFPMA, Geneva 1996.
42. Dolan, J.W., LC·GC Eur. 2001, 14,530-634.